Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: a multi-institutional, long-term experience (Q79847300)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

title

Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: a multi-institutional, long-term experience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Sisto Perdonà

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

Riccardo Autorino

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

Rocco Damiano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

Marco De Sio

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

Brunello Morrica

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

Luigi Gallo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

Giustino Silvestro

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

Antonio Farella

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

Sabino De Placido

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

Giuseppe Di Lorenzo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

75-83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure

26 December 2019

cites work

1 reference

7 January 2021

Transurethral resection of muscle-invasive bladder cancer: 10-year outcome

1 reference

7 January 2021

Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer?

1 reference

7 January 2021

RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system

1 reference

7 January 2021

An organ-preserving approach to muscle-invading transitional cell cancer of the bladder

1 reference

7 January 2021

Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study

1 reference

7 January 2021

Efficacy of Radiochemotherapy with Platin Derivatives Compared to Radiotherapy Alone in Organ-Sparing Treatment of Bladder Cancer

1 reference

7 January 2021

Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results

1 reference

7 January 2021

Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group

1 reference

7 January 2021

Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12

1 reference

7 January 2021

Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802

1 reference

7 January 2021

Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03

1 reference

7 January 2021

The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on

1 reference

7 January 2021

1 reference

7 January 2021

Benchmarks achieved in the delivery of radiation therapy for muscle-invasive bladder cancer

1 reference

7 January 2021

Bladder preservation by combined modality therapy for invasive bladder cancer.

1 reference

7 January 2021

Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer

1 reference

7 January 2021

Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program.

1 reference

7 January 2021

Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results

1 reference

7 January 2021

Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy

1 reference

7 January 2021

Conservative treatment with transurethral resection, neoadjuvant chemotherapy followed by radiochemotherapy in stage T2-3 transitional bladder cancer

1 reference

7 January 2021

Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer.

1 reference

7 January 2021

Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature

1 reference

7 January 2021

Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder

1 reference

7 January 2021

Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors

1 reference

7 January 2021

Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: a five-year follow-up

1 reference

7 January 2021

Organ preservation by combined modality treatment in bladder cancer: the European perspective

1 reference

7 January 2021

Identifiers

DOI

10.1002/CNCR.23137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18008364 AND SRC:MED&resulttype=core&format=json

26 December 2019

1 reference